S&P 500

88 EQT EQT Lifts Kakaku.com Takeover Bid Amid Competition
  • 📈 EQT raises Kakaku.com bid to JPY 3,570 per share.
  • 💰 Offer includes up to 68.32% premium over pre-speculation price.
  • 📅 Tender period extended until August 27, 2026 for approval.
 78 GOOG This AI Stock Is Down 13%, but Could Be the Safest One Out There
  • 📉 Stock trades 13% below $408.61 52-week high near $355.
  • 💰 Revenue jumped 24% to $119.8 billion last quarter.
  • ☁️ Google Cloud revenue surged 82% on AI demand.
 92 A Why Agilent Technologies Stock Triumphed on Thursday
  • 📈 Agilent shares jumped nearly 17% on strong quarterly earnings.
  • 💰 Q2 fiscal 2026 revenue reached $1.83 billion, up 10%.
  • 🚀 Non-GAAP net income surged 14% to $423 million.
 92 EA EA Acquired by PIF, Silver Lake, Affinity Partners
  • 🏦 Acquired by PIF, Silver Lake, and Affinity Partners at $210/share.
  • 📉 Shares delisted from NASDAQ following December 2025 shareholder ratification.
  • 👔 Andrew Wilson remains Chairman & CEO under new private ownership.
 88 MSCI MSCI rejig: Adani Energy, Groww, Laurus Labs, Lenskart shares in; Astral, SBI Cards out
  • 📈 Adani Energy, Groww, Laurus Labs, Lenskart added to MSCI India Index.
  • 📉 Astral, Balkrishna, SBI Cards excluded from standard; Astral moves to Small Cap.
  • 💰 Rebalancing projected to generate $1 billion net passive inflows into Indian equities.

Nuclear and Uranium

78 OKLO Why Oklo (OKLO) Is Up 8.5% After First Criticality And Initial Reactor ...
  • 🚀 Oklo achieved first criticality at Texas test reactor under DOE program.
  • 💰 Company recorded first quarterly sales of US$1.21 million validating commercial activity.
  • 📉 Quarterly net loss widened to US$48.54 million with basic loss of US$0.28.
 88 CCJ Invest in Cameco to buy in to the nuclear renaissance - MoneyWeek
  • 📈 Global uranium supply expected to be only 50% of demand by 2041.
  • 💰 2025 revenue rose 11% to $3.5 billion with EPS up 321%.
  • 🤝 Signed nine-year India deal for 22 million pounds worth C$2.6 billion.
 88 OKLO OKLO INC : NYSE - LinkedIn
  • 📈 Stoneblack initiates 'Speculative Buy' with $78 target implying ~90% upside.
  • 🏗️ Oklo received DOE approvals for Groves reactor with criticality targeted this month.
  • 💰 Company raised $1.182B net via January 2026 equity program.
 82 CCJ Here’s Why Cameco Corporation (CCJ) Outperformed in Q2
  • 📈 Aristotle Capital International Equity Strategy returned 4.99% gross in Q2 2023.
  • ⛏️ Cameco operates high-grade uranium mines at Cigar Lake and McArthur River.
  • 🤝 Westinghouse acquisition expected to enhance Cameco's downstream fuel services.
 78 CCJ News of the day: GDP gains, Ontario nickel mine approval, oilpatch ...
  • 🇨🇦 Canada's real GDP grew 0.3% in May with continued expansion.
  • ✅ Major Ontario nickel mine approved for US$2B construction and US$2.5B total capital.
  • 🔋 Nickel operations will support stainless steel and electric vehicle battery production.

Big Pharma

88 ABBV Cantor Fitzgerald Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock ...
  • 📈 Cantor Fitzgerald raised AbbVie price target to $285.
  • 📊 Q2 earnings beat estimates at $3.65 per share.
  • 💰 Revenue reached $16.99 billion with 10.2% growth.
 82 BIIB Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more
  • 📈 Biogen shares rose 0.7% after beating estimates and raising EPS guidance.
  • 📉 Vertiv stock fell 13% as organic revenue growth missed consensus forecasts.
  • ⚡ Generac jumped 5.5% on earnings of $2.91, far exceeding the $2.01 forecast.
 82 NVO Novo Nordisk shares in hot water after disappointing trial
  • 📉 Shares fell 8.6% after ZEUS trial failed main goal.
  • 💊 Drug lowered inflammation but did not prevent heart attacks.
  • ⚠️ Patients on drug faced more serious infections than placebo.
 78 BIIB Biogen Stock Rating Upgraded Amid Positive Data From Alzheimer's ...
  • 📈 Truist upgraded Biogen to Buy, raising target to $235.
  • ⚠️ Diranersen missed primary endpoint but slowed decline at 60 mg.
  • ✅ Drug reduced tau in spinal fluid and brain scans.
 78 NVO Novo Nordisk (NVO) Stock Looks Below Fair Value Despite Recent Setbacks
  • 📉 Stock fell 36.4% over three years with recent underperformance.
  • 💰 Trades at 11.1x P/E vs 24.7x peer average.
  • 📊 Fair value model suggests stock is undervalued by double.

Big Tech and AI

78 AMD AMD earnings are a key test for chips and momentum stocks. Here's what the options market is saying
  • 📉 AMD shares drop despite positive earnings amid market divergence.
  • 📊 Technical indicators signal a short bias for the stock.
  • 🏭 Sector rotation favors defensive stocks over IT hardware.
 88 GOOGL Warren Buffett's Berkshire Hathaway Buys $4.9B in Alphabet Shares: What ...
  • 📈 Berkshire bought 17.8M Alphabet shares worth $4.9B in Q3.
  • 🔄 Buffett shifts strategy, reducing Apple by $10.6B for tech.
  • 🚀 Alphabet stock jumped 3.5% after the massive stake reveal.
 88 ORCL Oracle Stock: Are AI Data Centers Creating a New Growth Story—or a New ...
  • 📈 Fiscal 2026 revenue hit $67.4B with cloud infrastructure up 77%.
  • 💰 Company holds $638B RPO backlog despite negative free cash flow.
  • 🏦 Raised $48B in debt and equity to fund AI expansion.
 78 IBM IBM Stock Price Prediction
  • 🎯 24/7 Wall St. targets $270.73 IBM stock in 12 months.
  • 📈 Optimistic scenario projects $322.46 gain, representing 38.7% upside.
  • 🛡️ Conservative floor set at $242.91 limits downside risk to 4.5%.
 72 PLTR Palantir Technologies (PLTR) Turning AI Demand into Profitable Growth ...
  • 🇮🇳 India invests ₹15.6B in AI over five years.
  • 📈 Palantir revenue grew 50% in Q1 2023.
  • 🤝 Partnerships with TCS and Infosys expand reach.

Biotech / Genomics

92 CRSP CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
  • 📈 CASGEVY revenue hit $76M in Q2 2026, up 151% year-over-year.
  • ✅ FDA approved CASGEVY for sickle cell disease in children aged 2+.
  • 💰 Cash and securities totaled $2.36 billion as of June 30, 2026.
 78 MRNA Moderna Q2 EPS Estimate Lifted by Brookline Capital Markets
  • 📈 Brookline raised Q2 2026 Moderna EPS estimate to ($1.97).
  • 💰 Moderna Q2 revenue hit $145M, beating the $102.93M consensus.
  • 📉 Q2 loss of ($1.97) beat expected ($2.03) loss per share.
 82 CRSP CRISPR Therapeutics Provides Business Update and Reports Second Quarter ...
  • 📅 CRISPR Therapeutics reported Q2 2026 results on August 3, 2026.
  • ✅ CASGEVY FDA approved for children as young as 2 years old.
  • 🤝 Vertex leads global development under a 60/40 profit-sharing agreement.
 78 MRNA Amundi Reduces Holdings in Moderna, Inc. $MRNA - Defense World
  • 📉 Amundi sold shares, retaining a $45.96 million stake.
  • 💰 Revenue hit $145M, beating estimates with a 2.1% rise.
  • 📉 Reported loss of $1.97 per share, better than expected.
 68 MRNA 11 Best Performing S&P 500 Stocks in the Last 10 Years (2026)
  • 📈 Moderna ranks in top 11 S&P 500 stocks with 925.2% decade gain.
  • 💉 RSV vaccine shows 83.7% efficacy against lower respiratory disease in older adults.
  • 📉 Deutsche Bank raised target to $225 but expects a loss this year.

Crypto and Blockchain

82 IREN IREN (IREN) vs. CORZ and APLD: Can Its AI Cloud Buildout Turn Contracted Demand Into Profits?
  • 📊 AI Cloud revenue doubled to $33.6M while total Q3 revenue fell to $144.8M.
  • 🔋 Secured 5GW power and 150k GPUs targeting $3.7B annual recurring revenue by 2026.
  • 🤝 Signed $3.4B five-year NVIDIA contract covering 60MW Blackwell capacity via prepayments.
 88 IREN IREN Completes Acquisition of Mirantis
  • 📅 IREN completed Mirantis acquisition on August 4, 2026.
  • 📜 Deal includes ~12.6M shares plus $40M cash and RSUs.
  • 🚀 Expands AI Cloud platform with enterprise software expertise.
 78 COIN Coinbase shares slide as revenue and earnings miss despite record market share
  • 📉 Shares slid >5% after Q2 adjusted loss of 40 cents vs 11-cent expectation.
  • 💰 Revenue fell 19% to $1.22B as transaction revenue dropped 22%.
  • 📊 Global crypto spot market share hit record 10.3% for third straight quarter.
 78 IREN Infrastructure Vs. Software: Can IREN Limited Capture The Real Value In AI
  • 🔄 IREN pivots from Bitcoin mining to AI infrastructure provider.
  • 💰 Secured $2.8B contracts covering 85% of $4B 2026 target.
  • 🤝 Major clients include Microsoft and Nvidia.
 68 IREN ABN Amro Investment Solutions Buys Shares of 15,648 IREN Limited $IREN
  • 📈 ABN Amro bought 15,648 shares worth $536,000 in Q1.
  • 🏢 IREN operates Australian bitcoin mining data centers.
  • 💰 Institutions now own 41.08% of outstanding stock.